Genus (LON:GNS) Receives “Buy” Rating from Berenberg Bank

Genus (LON:GNS)‘s stock had its “buy” rating reiterated by investment analysts at Berenberg Bank in a research note issued to investors on Thursday, Digital Look reports. They currently have a GBX 3,350 target price on the stock. Berenberg Bank’s target price indicates a potential upside of 62.95% from the company’s current price.

Genus Stock Performance

Shares of GNS stock opened at GBX 2,055.83 on Thursday. The firm has a market cap of £1.37 billion, a price-to-earnings ratio of 28.96, a PEG ratio of 2.87 and a beta of 0.90. Genus has a 52-week low of GBX 1,943 and a 52-week high of GBX 3,220. The company has a quick ratio of 1.08, a current ratio of 2.25 and a debt-to-equity ratio of 51.73. The company’s 50 day moving average is GBX 2,223.11 and its 200 day moving average is GBX 2,382.24.

Genus (LON:GNS) last posted its earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share for the quarter. Genus had a return on equity of 9.70% and a net margin of 7.07%. On average, sell-side analysts anticipate that Genus will post 70.9644323 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Celia Baxter bought 2,336 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was bought at an average price of GBX 2,140 per share, with a total value of £49,990.40. 0.71% of the stock is owned by insiders.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.